MYOTONIC DYSTROPHY TYPE 1 (DM1)

Clinical trials for MYOTONIC DYSTROPHY TYPE 1 (DM1) explained in plain language.

Never miss a new study

Get alerted when new MYOTONIC DYSTROPHY TYPE 1 (DM1) trials appear

Sign up with your email to follow new studies for MYOTONIC DYSTROPHY TYPE 1 (DM1), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 2 Completed 1

First human trial tests potential new treatment for rare muscle disease

Disease control Completed

This study tested the safety and effects of a new drug called AOC 1001 in adults with myotonic dystrophy type 1, a genetic muscle-wasting disease. Thirty-nine participants received either the drug or a placebo through an IV to see how their bodies handled it and if it affected th…

Matched conditions: MYOTONIC DYSTROPHY TYPE 1 (DM1)

Phase: PHASE1, PHASE2 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

MYOTONIC DYSTROPHY TYPE 1 (DM1)

Get alerted when new MYOTONIC DYSTROPHY TYPE 1 (DM1) trials appear

First human trial tests potential new treatment for rare muscle disease